Navigating the Unknown: EU HTA Regulation’s Impact On Commercial Confidentiality

 
• By Eliza Slawther

Company dossiers submitted for EU-level joint clinical assessments under the Health Technology Assessment Regulation will be made public. This could conflict with other strategic business decisions and should be planned for in advance, experts say.

Companies can request the redaction of confidential information in public JCA reports. (Shutterstock)

More from Health Technology Assessment

More from Interviews